Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

39.91
+0.45001.14%
Post-market: 39.910.00000.00%16:53 EDT
Volume:685.29K
Turnover:27.20M
Market Cap:3.77B
PE:-6.79
High:39.98
Open:39.57
Low:39.02
Close:39.46
Loading ...

Why Investors Shouldn't Be Surprised By Ultragenyx Pharmaceutical Inc.'s (NASDAQ:RARE) Low P/S

Simply Wall St.
·
03 Jul

Ultragenyx Receives FDA Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome Treatment

Reuters
·
27 Jun

Ultragenyx Receives Breakthrough Therapy Designation for Gtx-102 in Angelman Syndrome

THOMSON REUTERS
·
27 Jun

Ultragenyx Pharmaceutical Inc - Receives FDA Breakthrough Therapy Designation for Gtx-102

THOMSON REUTERS
·
27 Jun

Director Corazon Sanders Reports Disposal of Common Shares in Ultragenyx Pharmaceutical Inc

Reuters
·
24 Jun

Ultragenyx Pharmaceutical (RARE) Gets a Buy from TD Cowen

TIPRANKS
·
23 Jun

BRIEF-Ultragenyx reports inducement grant under Nasdaq listing rule

Reuters
·
21 Jun

Ultragenyx Awards 48,731 Restricted Stock Units to New Hires Under Inducement Plan

Reuters
·
21 Jun

Ultragenyx Pharma Price Target Maintained With a $64.00/Share by Guggenheim

Dow Jones
·
20 Jun

Buy Rating on Ultragenyx Pharmaceutical: Promising Potential of Setrusumab for Osteogenesis Imperfecta and Attractive Risk/Reward Profile

TIPRANKS
·
11 Jun

Ultragenyx Pharmaceutical (RARE) Receives a New Rating from William Blair

TIPRANKS
·
31 May

RBC Capital Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
30 May

Ultragenyx Pharmaceutical Inc : William Blair Initiates Coverage With Outperform Rating

THOMSON REUTERS
·
28 May

William Blair Initiates Ultragenyx Pharmaceutical at Outperform

MT Newswires Live
·
28 May

Ultragenyx initiated with an Outperform at William Blair

TIPRANKS
·
28 May

J.P. Morgan Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
23 May

Ultragenyx Announces Grant of Restricted Stock Units to New Employees Under Inducement Plan

Reuters
·
21 May

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
21 May

Ultragenyx Pharmaceutical Approves Key Proposals at Annual Meeting

TIPRANKS
·
20 May

Ultragenyx Pharmaceutical Inc. Conducted Annual Stockholders Meeting

Reuters
·
20 May